Sundial Growers Inc. (SNDL) stock plunged -11.07% to $0.466 in the pre-market trading. The firm recently reported that it filed new shelf registration statement. The most recent rating by CIBC, on August 17, 2020, is a Neutral.
Obalon Therapeutics Inc. (NASDAQ: OBLN) shares are trading down -10.87% at $2.05 at the time of writing. Company’s 52-week ranged between $0.62 to $2.14. Analysts have a consensus price target of $3.
Eastman Kodak Company (KODK) stock moved up 7.14 percent to $12.9 in the pre-market trading after the company gets a clean chit from the U.S. government.
American Airlines Group Inc. (AAL), a Airlines company, rose about 2.03% at $17.56 in pre-market trading Tuesday.
Zomedica Corp. (ZOM) gained over 2.45% at $0.18 in pre-market trading Tuesday December 08, 2020 after reporting that, with the hiring of Debra Rock to lead the Company’s Marketing Department, its internal commercial leadership team is complete.
Before the trading started on December 08, 2020, Tesla Inc. (TSLA) is down -0.35% to reach $639.5. It has been trading in a 52-week range of $65.45 to $607.80.
Nano Dimension Ltd. (NNDM) is up more than 8.55% at $7.24 in pre-market hours Tuesday December 08, 2020 following the declaration of its Pricing $180 million registered direct offering. The stock had dropped over -10.35% to $6.67 in the last trading session.
Apex Technology Acquisition Corporation (NASDAQ: APXT) shares are trading up 4.31% at $15.25 at the time of writing. Company’s 52-week ranged between $9.13 to $17.25.
FuelCell Energy Inc. (FCEL) stock soared 2.55% to $8.03 in the pre-market trading. The firm recently reported completion of the previously announced underwritten public offering of 39,696,320 shares of its common stock. The most recent rating by JP Morgan, on November 19, 2020, is a Neutral.
RMG Acquisition Corp. (RMG) gained over 3.24% at $17.2 in pre-market trading Tuesday December 08, 2020.
BlackBerry Limited (NYSE: BB) shares are trading up 4.24% at $8.6 at the time of writing. The AI security provider recently declared that it will report results for the third quarter of fiscal year 2021 at 5:30 p.m. ET on Thursday, December 17, 2020. The Company’s 52-week ranged between $2.70 to $9.69.
Kaixin Auto Holdings (KXIN) is up more than 6.9% at $4.65 in pre-market hours Tuesday December 08, 2020. The stock had dropped over -11.22% to $4.35 in the last trading session.
XPeng Inc. (XPEV) gained over 2.19% at $49.36 in pre-market trading Tuesday December 08, 2020 after declaring that it intends to offer and sell 40,000,000 American Depositary Shares.
Ideanomics Inc. (IDEX) is up more than 9.66% at $2.27 in pre-market hours Tuesday December 08, 2020. The stock had jumped over 2.48% to $2.07 in the last trading session.
HEXO Corp. (HEXO) stock plunged -4.95% to $0.96 in the pre-market trading following the proclamation of downward revision to its proposed share consolidation ratio. The most recent rating by Cantor Fitzgerald, on July 22, 2020, is a Neutral.
Before the trading started on December 08, 2020, Li Auto Inc. (LI) is up 3.21% to reach $32.5. It has been trading in a 52-week range of $14.31 to $47.70.
Kandi Technologies Group Inc. (NASDAQ: KNDI) shares are trading up 7.18% at $9.1 at the time of writing. The firm recently issued chairman’s letter to shareholders. Company’s 52-week ranged between $2.17 to $17.45.
Virgin Galactic Holdings Inc. (SPCE), a Aerospace & Defense company, rose about 6.12% at $35.87 in pre-market trading Tuesday.
Moderna Inc. (MRNA) grew over 3.44% at $165.01 in pre-market trading today after reporting that Canada exercises increased option for total of 40 million doses of mRNA vaccine candidate against COVID-19 (mRNA-1273).
Platinum Group Metals Ltd. (PLG) is up more than 17.21% at $4.7 in pre-market hours Tuesday December 08, 2020. The stock had jumped over 29.35% to $4.01 in the last trading session.
United Microelectronics Corporation (NYSE: UMC) shares are trading up 1.22% at $9.15 at the time of writing following the declaration of its unaudited net sales for the month of November 2020. Company’s 52-week ranged between $2.10 to $8.96.
Energy Fuels Inc. (UUUU) stock soared 6.32% to $3.03 in the pre-market trading. The most recent rating by Noble Capital Markets, on May 13, 2019, is a Market perform.
ToughBuilt Industries Inc. (TBLT), a Tools & Accessories company, dropped about -10.84% at $0.7356 in pre-market trading Tuesday after reporting the launch 14 new tool organization SKUs at LOWE’S nationwide.
IZEA Worldwide Inc. (NASDAQ: IZEA) shares are trading down -6.68% at $0.885 at the time of writing. Company’s 52-week ranged between $0.07 to $3.13.
Gran Tierra Energy Inc. (GTE) gained over 64.15% at $0.5 in pre-market trading Tuesday December 08, 2020 following the publication of a financial update and the Company’s 2021 capital budget and production guidance.
Electrameccanica Vehicles Corp. (SOLO) gained over 4.15% at $7.78 in pre-market trading Tuesday December 08, 2020.
Before the trading started on December 08, 2020, iBio Inc. (IBIO) is down -8.67% to reach $1.37 after revealing an underwritten public offering of its common stock. It has been trading in a 52-week range of $0.19 to $7.45.
Cinedigm Corp. (CIDM) is down more than -2.34% at $0.671 in pre-market hours Tuesday December 08, 2020. The stock had dropped over -1.63% to $0.69 in the last trading session.
CBAK Energy Technology Inc. (CBAT), a Electrical Equipment & Parts company, rose about 8.98% at $7.04 in pre-market trading Tuesday after declaring that its wholly owned subsidiary, Dalian CBAK Energy Technology Co., LTD signed a joint development agreement with Wuxi Lead Intelligent Equipment Co., Ltd..
Before the trading started on December 08, 2020, Torchlight Energy Resources Inc. (TRCH) is up 2.99% to reach $0.69. It has been trading in a 52-week range of $0.21 to $1.09.
Before the trading started on December 08, 2020, Sumo Logic Inc. (SUMO) is up 5.43% to reach $26.0 after releasing financial results for the third quarter of its fiscal 2021, ended October 31, 2020. It has been trading in a 52-week range of $16.71 to $30.29.
QEP Resources Inc. (QEP) is up more than 5.63% at $2.25 in pre-market hours Tuesday December 08, 2020. The stock had dropped over -1.39% to $2.13 in the last trading session.
ON Semiconductor Corporation (NASDAQ: ON) shares are trading up 4.63% at $31.99 at the time of writing. The firm lately revealed that Hassane El-Khoury has been named as the company’s president, chief executive officer and member of its board of directors. Company’s 52-week ranged between $8.17 to $30.04.
Uranium Energy Corp. (UEC) stock soared 11.89% to $1.6 in the pre-market trading. The most recent rating by Canaccord Genuity, on October 14, 2020, is a Speculative buy.
Stitch Fix Inc. (SFIX) gained over 33.27% at $47.75 in pre-market trading Tuesday December 08, 2020 following the releaseof its financial results for the first quarter of fiscal year 2021 ended October 31, 2020
Switchback Energy Acquisition Corporation (SBE) grew over 1.76% at $37.01 in pre-market trading today.
Stealth BioTherapeutics Corp (MITO) is down more than -1.34% at $1.47 in pre-market hours Tuesday December 08, 2020 after announcing appointment of Eve E. Slater, M.D., F.A.C.C. to its Board of Directors. The stock had jumped over 14.62% to $1.49 in the last trading session.
Gevo Inc. (GEVO) grew over 3.59% at $1.73 in pre-market trading today.
Before the trading started on December 08, 2020, Trillium Therapeutics Inc. (TRIL) is down -5.29% to reach $14.51 after presenting at the American Society of Hematology (ASH) Annual Meeting, taking place virtually from December 5-8, 2020. It has been trading in a 52-week range of $0.29 to $20.96.
Lizhi Inc. (LIZI) stock moved up 2.11 percent to $3.88 in the pre-market trading.
Dare Bioscience Inc. (DARE) stock soared 5.26% to $1.4 in the pre-market trading after declaring positive topline results from DARE-BVFREE, a Phase 3 trial of DARE-BV1 in patients diagnosed with bacterial vaginosis.
Top Ships Inc. (TOPS) gained over 6.04% at $1.58 in pre-market trading Tuesday December 08, 2020.
Westwater Resources Inc. (WWR) grew over 1.37% at $5.94 in pre-market trading today following update on pilot plant operations provided by company.
InterPrivate Acquisition Corp. (IPV) stock moved up 5.25 percent to $15.03 in the pre-market trading.
Before the trading started on December 08, 2020, Futu Holdings Limited (FUTU) is up 2.41% to reach $43.31 following the announcement of agreement to purchase shares by a leading global investment firm. It has been trading in a 52-week range of $8.16 to $51.10.
Tag: JAGX
-
Market Movers: What changed for these 45 stocks while you were sleeping
-
Jaguar Health (JAGX) Spikes Above 70% following the announcement of its Novel Proprietary Drug for ‘Long-Hauler’ COVID-19 Patients
Jaguar Health has decided to develop and commercialize Crofelemer for the treatment of COVID-19 recovery patients suffering from long-term diarrhea. The study is planned to begin in Europe.
Jaguar Health, Inc. (JAGX) stock is on a roll today after the company along with its wholly-owned subsidiary, Napo Pharmaceuticals announced that they are planning to develop and commercialize their novel proprietary drug, Crofelemer. This drug will be developed for the COVID-19 recovery patients that are suffering from inflammatory diarrhea or prophylaxis.
JAGX stock is skyrocketing on the initiation update of Crofelemer. The stock opened the trading at $0.21 and is currently trading at $0.36 continuing to soar by almost 74%. The trading volume is high at 90 million compared to the average volume of 6.4 million, as we write this.
Jaguar and Napo are planning to begin the study on a ‘long-hauler’ COVID-19 recovery patient population in Europe.The novel proprietary drug, Crofelemer, will indicate the symptomatic relief of inflammatory diarrhea that will be studied in the clinical testing.
The increasing COVID-19 cases have brought worse things to people as coronavirus patients are suffering from different issues. One of the major symptoms for COVID-19 patients is long-term diarrhea or other gastrointestinal disfunctions.
At the moment, the company is in talks with the Swiss Growth Forum on the potential merger of SPAC with an operational subsidiary of the Company. The subsidiary will be located in Europe that will have an exclusive license for developing and commercializing crofelemer and Mytesi®.
Based on the initial discussions, the company has reported that the agreement will include an upfront cash license fee of almost $2 million to $10 million to Napo. The cash payment will also include approximately $20 million for funding the European operation. It will also include equity ownership of 30%-49.5% for Napo in the European subsidiary, post-acquisition by the SPAC.
The agreement will also have other customary financial terms including transfer pricing and royalties upon the sale of crofelemer and Mytesi in Europe.
The “long-hauler” project is specifically associated with COVID-19 patients who have symptoms which may include diarrhea, pain, constipation, brain fog, cardiovascular effects, fatigue, and arthritis. The study will be based on solving patient problems having these symptoms.
Napo has already completed the intellectual property filings for the development of Crofelemer. With the indications of potential long-hauler project, the company is focused on IP protection.
Jaguar and Napo have defined the endpoints for the study before they commercialize their product for COVID-19 patients. The primary endpoints include prophylaxis, gut biome restoration, and reduction in inflammatory gut markers and viral fecal shedding.
-
20 Trending Stocks In Biotechnology Industry You Should Consider Buying
Investors are always looking for safe and secure investments and as a strong and profitable industry, the biotechnology industry is considered to be an attractive area of investment. This industry has experienced massive growth in recent years and is continuously adopting new technological advancements to keep pace with the fast-growing market. Biotechnology is a set of tools that uses living organisms to create or change a product, improve plants, trees, or animals, or develop microorganisms for specific uses.
Modern Biotechnology’s main focus is on medicine. The companies in this sector are involved in the development of new treatments for various complex diseases. Technology has always been at the heart of the biotechnology industry. As the new technologies emerged with the passage of time the efficiency of companies has also improved. Similarly, technological advancements have also changed the clinical trial process.
There are various other trends that the companies are following. Let see the top 20 companies in the biotechnology industry to get a better view:
Cassava Sciences Inc. (NASDAQ: SAVA)
Cassava Sciences Inc. (NASDAQ: SAVA) last closed at $11.47, in a 52-week range of $1.05 to $11.25. Analysts have a consensus price target of $17.00. Cassava Sciences Inc. (SAVA) has earlier announced the results of the Phase 2b study with its drug candidate Sumifilam, in Alzheimer’s disease. The clinical study which has received the funding by the National Institutes of Health (NIH) has shown the improvement in Alzheimer’s disease. Cassava Sciences Inc. (SAVA) market cap has remained high, hitting $242.02 M at the time of writing.
Inovio Pharmaceuticals Inc. (NASDAQ: INO)
Inovio Pharmaceuticals Inc. (NASDAQ: INO) stock soar by 10.21% to $16.94. The most recent rating by ROTH Capital, on July 01, 2020, is at a Sell. Inovio Pharmaceuticals Inc. (INO) has revealed that the US Food and Drug Administration (FDA) has informed the company that it has some questions related to the Phase 2/3 trial of its COVID-19 vaccine candidate INO-4800, including its CELLECTRA 2000 delivery device to be used in the trial. the company said that it will halt the trial until it clear all the ambiguities of FDA.
Sorrento Therapeutics Inc. (NASDAQ: SRNE)
Sorrento Therapeutics Inc. (NASDAQ: SRNE) Shares headed rising, higher as much as 4.84%. The most recent rating by H.C. Wainwright, on July 31, 2020, is at a Buy. Sorrento Therapeutics Inc. (SRNE) has earlier revealed the results of its’ multicenter, open-label, Phase 1b Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for the Treatment of Intractable Cancer Pain at the 14th Annual Pain Therapeutics Summit. The company has reported the encouraging results from its Phase 1b study to evaluate Epidural Resiniferatoxin Injection.
Vaxart Inc. (NASDAQ: VXRT)
Vaxart Inc. (NASDAQ: VXRT) rose 7.40% after gaining more than $0.51 on Friday. Pomerantz LLP is investigating claims on behalf of investors of Vaxart, Inc. Vaxart Inc. share price went from a low point around $0.25 to briefly over $17.49 in the past 52 weeks, though shares have since pulled back to $7.40. Vaxart Inc.’s market cap has remained high, hitting $752.43 M at the time of writing.
Novavax Inc. (NASDAQ: NVAX)
Novavax Inc. (NASDAQ: NVAX) stock soar by 10.86% to $113.56. The most recent rating by H.C. Wainwright, on August 06, 2020, is at a Buy. Par Sterile Products, LLC (Par Sterile) has entered into a non-exclusive agreement with Novavax, Inc. to provide fill-finish manufacturing services at its plant in Rochester, Michigan for NVX-CoV2373, Novavax’ COVID-19 vaccine candidate.
Onconova Therapeutics Inc. (NASDAQ: ONTX)
Onconova Therapeutics Inc. (NASDAQ: ONTX) Shares headed falling, lower as much as -3.23%. The most recent rating by H.C. Wainwright, on March 01, 2018, is at a Buy. Onconova Therapeutics Inc. (ONTX) earlier revealed that it has started the Phase 1 clinical trial in China for ON 123300 by its partner, HanX Biopharmaceuticals. Onconova has partnered with HanX Biopharmaceuticals in December 2017 for the development, registration, and commercialization of ON 123300 in China.
Jaguar Health Inc. (NASDAQ: JAGX)
Jaguar Health Inc. (NASDAQ: JAGX) last closed at $0.31, in a 52-week range of $0.29 to $1.38. Jaguar Health Inc. (JAGX) earlier revealed itis scheduled to participate in its first “Diarrhea Dialogues” virtual event on October 20 from 3:00 PM. The event, open to the financial and business community, will discuss the importance of supportive care for cancer patients as it relates to chronic lower GI tract distress, specifically with regard to debilitating diarrhea experienced as a result of cancer therapy.
Zogenix Inc. (NASDAQ: ZGNX)
Zogenix Inc. (NASDAQ: ZGNX) stock drop by -1.46% to $17.50. The most recent rating by Raymond James, on August 25, 2020, is at an Mkt perform. Zogenix Inc. (ZGNX) has revealed the pricing of its offering of $200,000,000 aggregate principal amount of 2.75% convertible senior notes due 2027 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
Trevena Inc. (NASDAQ: TRVN)
Trevena Inc. (NASDAQ: TRVN) Shares headed rising, higher as much as 4.04%. The most recent rating by Guggenheim, on September 14, 2020, is at a Buy. Trevena Inc. (TRVN) has earlier participated in three presentations at the virtual 2020 American College of Clinical Pharmacology (ACCP) Annual Meeting. The meetings have taken place from September 21st to 23rd, 2020.
VBI Vaccines Inc. (NASDAQ: VBIV)
VBI Vaccines Inc. (NASDAQ: VBIV) last closed at $3.08, in a 52-week range of $0.47 to $6.93. VBI Vaccines Inc. (VBIV) is scheduled to participate in upcoming presentations including Sci-B-Vac: Results on Ph3 Hep B vaccine, Targeting CMV for the development of effective GBM immunotherapy on September 29 and 30, 2020, respectively. It has today participated in the COVID-19 panel discussion on the topic: What existing treatments and vaccine development platforms show promise to control the rate of infection and spread?
Brickell Biotech Inc. (NASDAQ: BBI)
Brickell Biotech Inc. (NASDAQ: BBI) Shares headed rising, higher as much as 3.90%. The most recent rating by Lake Street, on August 28, 2020, is at a Buy. Brickell Biotech Inc. (BBI) has revealed that its Japanese development partner, Kaken Pharmaceutical Co., Ltd. has received approval to manufacture and market sofpironium bromide gel, 5% under the brand name ECCLOCK in Japan for the treatment of primary axillary (underarm) hyperhidrosis.
VYNE Therapeutics Inc. (NASDAQ: VYNE)
VYNE Therapeutics Inc. (NASDAQ: VYNE) Shares headed falling, lower as much as -6.17%. VYNE Therapeutics Inc. (VYNE) has revealed that the Company will host a physician symposium on AMZEEQ and ZILXI™ on Thursday, October 1, 2020. VYNE market cap has remained high, hitting $271.70-M at the time of writing.
Acorda Therapeutics Inc. (NASDAQ: ACOR)
Acorda Therapeutics Inc. (NASDAQ: ACOR) shares were trading up 30.13% at $0.62 at the time of writing on Friday. Acorda Therapeutics Inc. (NASDAQ: ACOR) share price went from a low point around $0.42 to briefly over $3.27 in the past 52 weeks, though shares have since pulled back to $0.62. ACOR market cap has remained high, hitting $22.70M at the time of writing, giving it a price-to-sales ratio of more than 0. If we look at the recent analyst rating ACOR, H.C. Wainwright downgraded coverage on ACOR shares with a Neutral rating.
Moderna Inc. (NASDAQ: MRNA)
Moderna Inc. (NASDAQ: MRNA) last closed at $69.47, in a 52-week range of $13.53 to $95.21. Analysts have a consensus price target of $91.90. Moderna Inc. (MRNA) has moved up 413.45% from its 52-weeks low and moved down -327.03% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 17.30. This company’s market capitalization has remained high, hitting $25.72 billion at the time of writing.
iBio Inc. (AMEX: IBIO)
iBio Inc. (AMEX: IBIO) rose 7.77% after gaining more than $0.15 on Friday. iBio Inc. (IBIO) share price went from a low point around $0.05 to briefly over $7.45 in the past 52 weeks, though shares have since pulled back to $2.08. iBio Inc. has moved up 4060.00% from its 52-weeks low and moved down -72.08% from its 52-weeks high. IBIO market cap has remained high, hitting $336.61 M at the time of writing.
Akebia Therapeutics Inc. (NASDAQ: AKBA)
Akebia Therapeutics Inc. (NASDAQ: AKBA) rose 0.81% after gaining more than $0.02 on Friday. In the past 52-weeks of trading, this company’s stock has fluctuated between the low of $2.34 and a high of $13.71. It has moved up 5.98% from its 52-weeks low and moved down -8191% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 2.30. This company’s market capitalization has remained high, hitting $347.50 million at the time of writing.
Vaccinex Inc. (NASDAQ: VCNX)
Vaccinex Inc. (NASDAQ: VCNX) stock drop by -1.10% to $1.79. The most recent rating by BTIG Research, on September 23, 2020, is at a Neutral. Vaccinex Inc. (VCNX) share price went from a low point around $1.70 to briefly over $12.23 in the past 52 weeks, though shares have since pulled back to $1.79. VCNX has moved up 5.29% from its 52-weeks low and moved down -85.36% from its 52-weeks high. VCNX market cap has remained high, hitting $36.19M at the time of writing.
Ocugen Inc. (NASDAQ: OCGN)
Ocugen Inc. (NASDAQ: OCGN) rose 2.29% after gaining more than $0.0 on Friday. In the past 52-weeks of trading, this company’s stock has fluctuated between the low of $0.17 and a high of $16.80. It has moved up 78.53% from its 52-weeks low and moved down -98.19% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 3.30. This company’s market capitalization has remained high, hitting $40.03 million at the time of writing.
9 Meters Biopharma Inc. (NASDAQ: NMTR)
9 Meters Biopharma Inc. (NMTR) last closed at $0.76, in a 52-week range of $0.37 to $1.22. 9 Meters Biopharma Inc. (NMTR) has moved up 106.59% from its 52-weeks low and moved down -37.33% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 1.30. This company’s market capitalization has remained high, hitting $101.25 million at the time of writing.
Clovis Oncology Inc. (NASDAQ: CLVS)
Clovis Oncology Inc. (NASDAQ: CLVS) stock soar by 3.25% to $5.88. The most recent rating by H.C. Wainwright, on May 18, 2020, is at a Buy. Clovis Oncology Inc. (CLVS) share price went from a low point around $2.93 to briefly over $17.37 in the past 52 weeks, though shares have since pulled back to $5.88. CLVS has moved up 100.68% from its 52-weeks low and moved down -66.15% from its 52-weeks high. CLVS market cap has remained high, hitting $502.33M at the time of writing.